BLUO acquires AlzChem Group from Evonik - MarketLine Financial Deals

BLUO acquires AlzChem Group from Evonik

BLUO acquires AlzChem Group from Evonik - MarketLine Financial Deals
BLUO acquires AlzChem Group from Evonik
Published Oct 27, 2009
2 pages — Published Oct 27, 2009
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

BLUO SICAV-SIF, a Luxembourg-based private equity fund, has acquired AlzChem Group from Evonik Industries AG, a Germany-based manufacturer of specialty chemicals, for EUR78.5 million in cash, excluding debt.

  
Source:
Document ID
MA12117_091105
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "BLUO acquires AlzChem Group from Evonik" Oct 27, 2009. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/BLUO-acquires-AlzChem-Group-from-Evonik-2052-13699>
  
APA:
MarketLine Financial Deals. (2009). BLUO acquires AlzChem Group from Evonik Oct 27, 2009. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/BLUO-acquires-AlzChem-Group-from-Evonik-2052-13699>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.